chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse practitioner refers to a 13 month old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 12-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Skin burning like a severe sunburn on right upper back from base of neck to bottom of scapula and wrapping under arm to underneath right breast. It hurts all the time and is worse when anything including clothes touch it. Also had slight flu-type symptoms, but those are not worrisome to me and disappeared. The burning sensation continues.
The patient is experiencing pain and swelling of the neck on the left side. The patient had the vaccine on his left arm. He said his arm is sore but his neck is sensitive to the touch. We discussed using warm compresses. He indicated he would seek medical care if it got any worse. He was not having any other symptoms.
the white area in his eye was bloody on the right side/blood in his eye; a little temperature/ low grade fever; back was hurting as if he did did 500 push ups; flu like symptoms; cold sweats; left eyelid started swelling/swollen eyelids; puffy eye; conjunctivitis/pink eye; muscle aches; This spontaneous case was reported by a pharmacist and describes the occurrence of CONJUNCTIVAL HAEMORRHAGE (the white area in his eye was bloody on the right side/blood in his eye) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (INSULIN NOVOLIN), METFORMIN, GLIMEPIRIDE (AMARYL), LOSARTAN POTASSIUM (COZAAR), CLOPIDOGREL BISULFATE (PLAVIX) and METOPROLOL for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONJUNCTIVAL HAEMORRHAGE (the white area in his eye was bloody on the right side/blood in his eye) (seriousness criterion medically significant), PYREXIA (a little temperature/ low grade fever), BACK PAIN (back was hurting as if he did did 500 push ups), INFLUENZA LIKE ILLNESS (flu like symptoms), COLD SWEAT (cold sweats), SWELLING OF EYELID (left eyelid started swelling/swollen eyelids), PERIORBITAL SWELLING (puffy eye), CONJUNCTIVITIS (conjunctivitis/pink eye) and MYALGIA (muscle aches). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse reaction, at an unspecified dose and frequency. At the time of the report, CONJUNCTIVAL HAEMORRHAGE (the white area in his eye was bloody on the right side/blood in his eye), SWELLING OF EYELID (left eyelid started swelling/swollen eyelids), PERIORBITAL SWELLING (puffy eye) and CONJUNCTIVITIS (conjunctivitis/pink eye) outcome was unknown and PYREXIA (a little temperature/ low grade fever), BACK PAIN (back was hurting as if he did did 500 push ups), INFLUENZA LIKE ILLNESS (flu like symptoms), COLD SWEAT (cold sweats) and MYALGIA (muscle aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Pharmacist states that he read on a website that the vaccine had been linked to infections such as conjunctivitis, pink eye, and swollen eyelids.     Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up contains new events; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
PATIENT STATED HE HAD HARDING, RAISED AREA AND SORENESS TO INJECTION SITE (RIGHT ARM) AFTER LEAVING CENTER. HE NOTICED THAT HIS BODY TEMPERATURE WAS ELEVATED ON 3 SEPARATE TIMES TO BE AT 99.7 AFTER RECEIVING TETANUS SHOT OVER A FEW WEEKS, ALSO STATED THAT HE WAS NOT FEELING SICK. PATIENT SAID HE TOOK IBUPROFEN TO RELIEVE THE SORENESS IN RIGHT ARM.
Person was given 0.3cc dose of Janssen Booster dose instead of standard 0.5 cc. health department notified and Manufacturer (Janssen) notified and all persons reported to Janssen Manufacturer for their Pharmacy department, recommendations from the Manufacturer and with agreement from health department are to notify all of the recipients that received an incorrect dose and submit a VAERS report for each.
patient reported having a rash which was likely to be shingles; patient reported having a rash which was likely to be shingles; This is a spontaneous report from a contactable pharmacist. A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that the patient came to see one of their primary care providers. The patient reported having a rash which was likely to be shingles, 3-4 days after getting the BNT162B2 first dose. The reporter inquired on what was the recommendation for the second dose with the active shingles infection. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Dose administered too early and incorrect formulation, should have been bivalent instead of monovalent
Her arm was sore; This is a spontaneous report from contactable consumer (caregiver on behalf of her mother). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration on 24Feb2021 (Batch/Lot number: Unknown) as a single dose for COVID-19 immunisation. Medical history included knee pain (knee hurts a lot because of the cold). Concomitant medications were not reported.  The patient experienced her arm was sore on an unspecified. The patient was due to get her second dose, but her knee hurts a lot and she wants to change her appointment. The caregiver reported that after the first dose, only her arm was sore, the knee pain was something else, because of the cold. The outcome of event sore arm was unknown.  No follow-up attempts possible; no request for batch number will be pursued.
she began experiencing watery vomiting and diarrhea; she began experiencing watery vomiting and diarrhea; She also has chills; was having a hot flash; felt like she was going to faint/pass out; This is a spontaneous report from a contactable consumer. A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 03Apr2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 05Apr2021, the patient she was at work and felt like she was having a hot flash, then felt like she was going to faint/pass out. The following day (06Apr2021) she began experiencing watery vomiting and diarrhea. She also had chills.  The patient wanted to know if this is normal and was also asking if she experienced these side effects because she weighs 110 lbs. The outcome of the events was unknown.  No follow-up attempts are possible, information about the batch number cannot be obtained.
a shortness of breath; difficulty swallowing food; Lots of tiredness; feeling weak; warm; nausea; fatigue; body Aches; couldn't move her arm although now she can; 4th day post vaccination, she had red spots; itchiness at the vaccination site; The red spots that are hard to touch and similar to chicken pox; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Lots of tiredness), ASTHENIA (feeling weak), VACCINATION SITE WARMTH (warm), NAUSEA (nausea) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FATIGUE (Lots of tiredness), ASTHENIA (feeling weak), VACCINATION SITE WARMTH (warm), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (body Aches), HYPOKINESIA (couldn't move her arm although now she can), VACCINATION SITE ERYTHEMA (4th day post vaccination, she had red spots), VACCINATION SITE PRURITUS (itchiness at the vaccination site), VACCINATION SITE ERYTHEMA (The red spots that are hard to touch and similar to chicken pox) and DYSPHAGIA (difficulty swallowing food). On an unknown date, the patient experienced DYSPNOEA (a shortness of breath). At the time of the report, FATIGUE (Lots of tiredness), ASTHENIA (feeling weak), VACCINATION SITE WARMTH (warm), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (body Aches), HYPOKINESIA (couldn't move her arm although now she can), VACCINATION SITE ERYTHEMA (4th day post vaccination, she had red spots), VACCINATION SITE PRURITUS (itchiness at the vaccination site), VACCINATION SITE ERYTHEMA (The red spots that are hard to touch and similar to chicken pox), DYSPNOEA (a shortness of breath) and DYSPHAGIA (difficulty swallowing food) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included  includes warm patches and pain pills.   Reporter did not allow further contact
Vaccination at 11:30 am on 9/11/19.  By 1 pm headache was noted then body aches.  Chills began at 7 pm leading to an early bedtime at 8 pm.  The next morning at 6:30 am (9/12/19) she had dizziness.  She continued to feel dizzy and passed out.  Her husband was present.  She had no memory of passing out.  She went to the ER and received fluids, toradol,  and Zofran.  She was released from the ER around 10:30 am and slept at home the rest of the day.  She also did not work the next day (9/13/19) and napped off and on all day.  She was tired the following day but felt better.
This spontaneous report was received from a medical assistant referring to a 4 month old male patient. The patient had not pertinent medical history, drug reactions/allergies or concurrent conditions. The patient's concomitant medications were not reported. On 01-NOV-2016, the  patient was vaccinated with a dose of ROTATEQ lot # M006111 with expiration date 18-NOV-2017, per oral, for prophylaxis. On 23-JAN-2017, the  patient was vaccinated with another dose of ROTATEQ lot # M031807 with expiration date 02-APR-2018, per oral, for prophylaxis. On 13-MAR-2017, the patient was vaccinated with the last dose of ROTATEQ lot # M031807 with expiration date 02-APR-2018, per oral, for prophylaxis. On 27-MAR-2017, the patient developed fever, but the exact patient's body temperature was unknown. On an unspecified date after this, the patient was admitted to a hospital and was diagnosed with Kawasaki disease with aseptic meningitis. It was unknown if any treatment was given to the patient or if any laboratory diagnostic test was performed. On another unspecified date, the patient recovered from the events and was discharged from hospital. At the time of reporting, the causality assessment between the events and ROTATEQ was not provided. The reporter considered Kawasaki disease and aseptic meningitis to be life threatening events. Upon internal review, Kawasaki disease and aseptic meningitis were determined to be medically significant events.
Pt presented to ED On 1/15/21 reporting worsening asthma symptoms with no relief from home treatments and feels the worsening of symptoms to be related to the Moderna vaccine. Pt now reports allergy to Moderna vaccine but did receive J&J vaccine in June 2021.
pt recv vax & 3wk post vax pt exp a sz;the woman did not think the sz was r/but wanted to inquire if the pt should receive the 3rd dose of vax;
This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and PRODUCT DOSE OMISSION ISSUE (2nd Moderna Vaccination outside of 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history was reported.). On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). On 01-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd Moderna Vaccination outside of 42 days). On 01-Apr-2021, PRODUCT DOSE OMISSION ISSUE (2nd Moderna Vaccination outside of 42 days) had resolved. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided.
10mins post vaccination pt had 1 episode of vomiting. Vitals: 13:11 95/53, 72, 18, 99% -- > 13:26 98/58, 67, 17, 98% Pt improved. Pt stable and released from the vaccination site w/ no residual s/sx.
Patient presented with UTI symptoms but also had a COVID exposure. She also has a cough, congestion and sore throat.
This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 97-year-old male patient who received SHINGRIX (batch number 3Z4KL, expiry date 30th January 2020). Concomitant products included carvedilol, Alendronate, Furosemide, Levothyroxine and ELIQUIS. On 31st January 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 31st January 2018, less than a day after receiving SHINGRIX, the patient experienced general body pain, neck pain and headache. On an unknown date, the outcome of the general body pain, neck pain and headache were not recovered/not resolved. The reporter considered the general body pain, neck pain and headache to be probably related to SHINGRIX. Additional information was reported as follows: The pharmacist reported that the patient planned to continue follow-up with his physician on an unknown date.
Client is here today for her 2nd Pfizer COVID vaccine. She received her first Pfizer COVID vaccine on 08/23/21 lot # FC3183 exp. 9/17/2021. RN asked client how she did with her first Pfizer COVID vaccine. Language interpreter was used since client is foreign speaking only. Language interpreter interpreted for the remainder of PHN?s assistant with client. With her first dose Pfizer COVID vaccine, she reported she had the following symptoms for one week: heavy body, shortness of breath, chest heavy/pressure, and weakness. Client reported that she didn't take any medications for any of her symptoms. She denied any chronic illnesses or any known allergies. Client stated she didn't follow-up with her primary care provider. PHN took her vitals today: blood pressure 117/75, pulse 54, respiration 18, and oxygen saturation rate 99%. PHN sent a medical consult to the clinical lead RN to get an approval for her 2nd dose. Clinical lead RN sent the medical consult to Dr. who approved for her to get her 2nd dose Pfizer COVID vaccine with 30 minutes observation. Client received her 2nd dose Pfizer COVID vaccine today (9.21.21) lot # FF8839 exp. 12/2021 at 1912 on her left arm. PHN educated client to seek emergency care if she experienced any adverse reactions and provided her with Pfizer fact sheet. She experienced no symptoms with her 2nd dose at the observation area and left the vaccination site in a steady gait at 1942.
Received the vaccines at about 10.45 AM was ok until evening then started feeling Dizzy and light headedness, after dinner felt dizzier and passed out at the counter, wife was beside him and able to hold him and called 911. Symptoms looks like Vasovagal syncope.
2 1/2 x 3 1/2 localized patch of erythema with increased thickness. Non tender to touch site on (L) upper thigh. Puncture site with scab and non-draining to Lt leg.
Local redness at Smallpox vaccination site, headache, unable to hold food down for 3 days. Taken Ibuprofin (2 tablets for a total of 800mg) Visited Emergency room, quarters for one day as per ER.
Exposure to Covid 19 either on the date of vaccine (2/13/21) or shortly thereafter.  Symptoms of Covid started on Monday (2/15) early morning following shot.  Dr. ordered Covid test on Weds. (2/17). Taken by ambulance to Hospital, approx. 7 pm on Saturday (2/20) with dehydration, low oxygen levels, confusion, shaking and cough.  Admitted to hospital with threats of ventilator up until Weds (2/24) when he was intubated, proned and FINALLY given hydration via IV fluids.  He went into kidney failure on Thursday (2/25) and put on dialysis.  Other organs began shutting down and was taken off the ventilator on Friday (2/26) and did not recover.  He passed away just before 4:00 p.m. on 2/26/21.
After vaccination I experienced the expected soreness in my arm and general malaise for 48 hours.  Eight days later, I woke up with large area of redness and warmth around the vaccination site.  Visited urgent care, cause it was Sunday, and was diagnosed with cellulitis of the arm.  I was given Bactrim DS 800mg BID x 7 days.   On March 1st, 2021 I contacted my doctor, who said that I may not have cellulitis, but an adverse effect to the Moderna vaccine and he has seen similar reactions to Moderna with his office staff.
Nausea, vomiting, arm pain and inability to raise arm for one week, jaw pain and broke tooth that got a clean bill of health from a dentist one week before. Had to have a root canal to repair but no decay found; all from 1st Pfizer covid vaccine 5/19/21 Fever, stiff, neck, headache, Meningitis symptoms and lock jaw from second dose of Pfiser covid vaccine given 6/10/21 Symptoms from 1st dose started within one hr of vaccine. Symptoms from 2nd dose started within 5 days of vaccine and lasted for up to almost 3 weeks. Very afraid of any booster at this point. Had native Covid in Nov 2020 and it wasnt as bad as the side effects of the vaccine.
About a half hour following injection, patient's left arm was very sore and red at the site.  Within 2-3 hours the injection site was getting painful.  By the evening of her vaccination she was in a lot of pain and could hardly move her left arm at the shoulder area.  The proximal arm and shoulder area now hurts so much that she cannot lift it.. She does not have any numbness of her forearm or hands. She can move her hand and fingers. The pain is focused on her lateral proximal arm area where the needle injection was. However the pain does move up over her shoulder into her upper back.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old male patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Pancreatitis" (unspecified if ongoing); "Allergy to sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2023) Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 10Sep2023 to 13Sep2023.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300305786 Same patient, Different product and events;
6-25-08 to hospital with febrile seizures; on DEPAKOTE; had EEG, CT & labs.
My one year old was vaccinated on 1/29/2018 with the varicella vaccination and on 2/7/2018 has a full case of chicken pox.
Patient advised day of the vaccine had a large lump at vaccination site (9/21/23), then day 2 lump gone but red rash that is warm to touch formed at vaccination site (9/22/23). Patient marked rash and applied cool compresses. Today (9/23/23) presented with rash spreading outside of marked site and nurse advised her possible allergic reaction to take Benadryl but to call md if that does not stop rash for an appointment.
1st dose 3/8/2021 - long term, almost debilitating muscle and joint pain & discomfort for 4 weeks above the injection site in left arm and left shoulder joint.  As the pain ended, took 2d dose 3 days later. 2d dose occurred 4/9/2021- similar long-term, almost debilitating muscle and joint pain, same location for a 6-7 week period. Treatment included otc analgesic cream & acetaminophen.  Eased pain and discomfort somewhat. Attribute some of this reaction to constant use and resultant wear & tear of upper body and arms due to manual wheelchair use and transfer from chair to bed, shower, vehicle driver's seat in daily routine.  Pt is otherwise healthy active employed male.
Patient received 2nd dose of Moderna 7 days earlier than recommended. After administration of vaccine and monitoring, patient did not report any signs and symptoms from vaccine administration.
Severe joint pain in elbows, wrists, fingers, hips,knees, and ankles beginning approx 6 - 7 hrs after FluMist (not certain if related) joints felt internally inflamed. Had difficulty walking due to pain, holding a cup and writing with a pen. Joint pain resolved in 24 hours (did miss work due to the pain). Took Ibuprofen around the clock and applied warm packs to joints.
C/o thirst.  Child was noted by sisters to have "appeared to pass out" off of stool and exhibited "jerky seizure - like motions of extremities".  Mother did not witness fall off stool and seizure - like activity.
Developed itchy feel with a greenish-tinged rash, sought medical help on Friday 11/13/09 and MD felt that rash was related to vaccination. Rx BENEDRYL tablets. By Monday 11/16 noted rash/itch on (L) side of trunk, MD ordered PREDNISONE oral --> totally recovered by 11/16 night.
Arm swelling from shoulder to elbow, extreme pain and sensitivity, headaches, nausea, vomiting, rash on torso,   long term effects- confusion, brain fog, severe fatigue, ongoing rash/breakouts under arms,  joint pain, weight gain, hair thinning, heart palpitations,  This is effecting my life
This spontaneous report was received from a pharmacist referring to an unspecified number of patients of unknown age and gender. Information about the patient's medical histories and concurrent conditions was not provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # L037561 expiration date: 29-SEP-2017 (administration routes were not reported). No concomitant therapies were reported. The pharmacist stated that he had no knowledge of adverse events were reported or not. This is one of several reports from the same reporter. Additional information is not expected, since there was no consent to contact the reporter to follow up.
Lethargic. Chills. Shaking. Headache. Body aches. Can hardly move. This happened 10.5 hours after injection.  The first injection on February 24, 2021, was the same, only the side effects started soon thereafter. like 3 hours.  I did not report it at that time. This second injection is worse, so I felt a need to report it.